Loading…

Novel near-infrared II aggregation-induced emission dots for in vivo bioimaging

Near-infrared II fluorescence imaging holds great promise for imaging and imaging-guided surgery with deep penetration and high spatiotemporal resolution. However, most NIR-II aromatic luminophores suffer from the notorious aggregation-caused quenching (ACQ) effect in the aqueous solution, which lar...

Full description

Saved in:
Bibliographic Details
Published in:Chemical science (Cambridge) 2019-01, Vol.10 (4), p.1219-1226
Main Authors: Lin, Jiacheng, Zeng, Xiaodong, Xiao, Yuling, Tang, Lin, Nong, Jinxia, Liu, Yufang, Zhou, Hui, Ding, Bingbing, Xu, Fuchun, Tong, Hanxing, Deng, Zixin, Hong, Xuechuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Near-infrared II fluorescence imaging holds great promise for imaging and imaging-guided surgery with deep penetration and high spatiotemporal resolution. However, most NIR-II aromatic luminophores suffer from the notorious aggregation-caused quenching (ACQ) effect in the aqueous solution, which largely hinders their biomedical application . In this study, the first NIR-II organic aggregation-induced emission (AIE) fluorophore ( ), encapsulated as nanoparticles ( dots) for biomedical imaging, was designed and synthesized. The NIR-II AIE dots showed high temporal resolution, high photostability, outstanding water-solubility and biocompatibility and . The dots were further used for long-term breast tumor imaging and visualizing tumor-feeding blood vessels, long-term hind limb vasculature and incomplete hind limb ischemia. More importantly, as a proof-of-concept, this is the first time that non-invasive and real-time NIR-II imaging of the gastrointestinal tract in health and disease has been performed, making the AIE dots a promising tool for gastrointestinal (GI) tract research, such as understanding the healthy status of GI peristalsis, diagnosing and evaluating intestinal motility dysfunction, and assessing drug effects on intestinal obstruction.
ISSN:2041-6520
2041-6539
DOI:10.1039/c8sc04363a